Cardiovascular Devices Market Report and Forecast 2025-2034
Description
The global cardiovascular devices market was valued at USD 56.50 Billion in 2024 , driven by increasing incidence of cardiovascular conditions across the globe. The market is expected to grow at a CAGR of 6.36% during the forecast period of 2025-2034, with the values likely to reach USD 104.67 Billion by 2034 .
Global Cardiovascular Devices Market Overview
The huge rise in the prevalence of chronic heart disease is driving the growth of the global market for cardiovascular devices. This increase in demand is encouraging more healthcare providers to use cutting-edge cardiac technology for diagnostic and surgical applications. Additionally, the market has grown because of the declining costs of essential cardiovascular treatment devices, especially in developing countries like India.
Data based on the UK Biobank report, underscored the critical importance of investing in research and development efforts aimed at promoting cardiovascular health (CVH) and preventing cardiometabolic diseases. The findings reveal that maintaining ideal CVH significantly reduces the risk of all-cause and cardiometabolic disease-related mortality, leading to substantial gains in life expectancy. For instance, among participants with cardiometabolic disease, having ideal CVH was associated with life expectancy gains of 5.50 years for males and 4.20 years for females, at an index age of 45 years. As a result, rising market is predicted to be significantly impacted by surge in investments and fundings as well.
Global Cardiovascular Devices Market Growth Drivers
Rising Prevalence of Chronic Cardiac Diseases
Globally, the prevalence of chronic heart disease has significantly increased, which has raised demand for cardiovascular devices. Numerous reasons, such as sedentary lifestyles, improper diet, and an aging population are driving this trend. According to projections from the American Heart Association, in 2020, the percentage of global deaths attributed to cardiovascular disease escalated from 28.9% to 36.3%. Furthermore, in terms of years of lives lost, cardiovascular disease is anticipated to transition from the fourth to the foremost position in ranking. This is leading to an increased application of cardiovascular devices, intended to combat the burden of rising cardiac morbidities.
Advancements in Technology to Meet the Increasing Cardiovascular Devices Market Demand
Technological advancements in cardiovascular medicines have ushered in a transformative era, where innovations like minimally invasive procedures, advanced imaging techniques, and the integration of artificial intelligence (AI) are revolutionizing both surgical and diagnostic approaches. Notably, AI or machine learning algorithms have become indispensable tools in the diagnosis and treatment of acute stroke. It helps by automating the detection of intracranial hemorrhage and large vessel occlusions on CT scans, while also accurately identifying early ischemic changes without the need for diffusion-weighted MRI.
Reduced Prices of Cardiovascular Therapeutic Devices
The decreased prices of crucial cardiovascular therapeutic devices, such as coronary stents, have made treatments more accessible, particularly in developing countries. This affordability has led to increased adoption rates and a broader patient population seeking cardiac interventions.
Global Cardiovascular Devices Market Trends
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
Adoption of Remote Monitoring Technologies
Remote monitoring technologies, such as wearable devices and telemedicine solutions, enable continuous monitoring of cardiac health, improving patients care and outcomes. Cardiovascular devices are experiencing an increased integration of such technologies to expand its reach and facilitate more effective management of chronic cardiac conditions.
Growth in Demand for Transcatheter Therapies
Transcatheter therapies, including transcatheter aortic valve replacement (TVAR) and transcatheter mitral valve repair (TMVR), are gaining traction due to its minimally invasive nature and efficacy.
Expansion of Remote Consultation Services
This trend facilitates virtual appointments with cardiologists, enabling patients to receive timely guidance, and adjust treatment plans. This not only offers enhanced convenience for patients but also optimizes healthcare resources while reduces the burden on healthcare facilities.
Increased Consolidation and Strategic Acquisitions
In recent years, consolidation efforts and strategic acquisitions by major firms have increased significantly in the cardiovascular devices market. Through mergers and acquisitions businesses are actively looking to diversify their product lines, improve their technological prowess, and increase their market share. Through these calculated actions, businesses can have access to new technologies, intellectual properties, and distribution networks, improving their ability to adapt to changing consumer demands and market conditions. By encouraging innovation, optimizing processes, and eventually enhancing product offers and consumer pleasure, these consolidation attempts are changing the market. They may also result in more competition and efficiency.
Global Cardiovascular Devices Market Segmentation
Cardiovascular Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Device Type Electrocardiography (ECG)
Remote Cardiac Monitoring
Others Pacemakers
Stents
Heart Valve
Others
Market Breakup by Application
Market Segmentation Based on Device Types Poised for Growth
In terms of device types, the market segmentation includes diagnostic and monitoring devices, along with therapeutic and surgical devices. Diagnostic and monitoring devices encompass electrocardiography (ECG), remote cardiac monitoring, and other advanced technologies. The increasing prevalence of cardiovascular diseases, coupled with the rising demand for early detection and continuous monitoring, is expected to drive significant growth in this segment. On the other hand, therapeutic and surgical devices such as pacemakers, stents, heart valves, and other interventional tools are vital for treating various cardiovascular conditions. The adoption of minimally invasive procedures and advancements in device technologies are likely to propel the market share of this segment.
Market Breakdown by Applications set to Drive Market Growth
Market segmentation based on applications in the cardiovascular devices market includes coronary artery disease, heart failure, and other related conditions, reflecting the escalating global burden of these diseases and the demand for effective diagnostic and therapeutic interventions. The ARIC study estimates an annual incidence of 605,000 new myocardial infraction attacks and 200,000 recurrent attacks, with 170,000 categorized as silent events. Disparities in care are evident, as an analysis of the National inpatient sample revealed that females are less likely to undergo coronary intervention compared to males, with a consequent higher risk of mortality. Consequently, the market share based on application areas is projected to be contribute a significant value to the market.
Global Cardiovascular Devices Market Analysis by Region
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa are all included in the regional market analysis. With their sophisticated healthcare systems and presence of top medical device producers, North America and Europe are expected to hold a sizable portion of the market. Its supremacy is partly attributed to the existence of well-established healthcare systems and advantageous payment regulations. However, due to reasons like rising healthcare costs, and easier access to cutting-edge healthcare services, Asia Pacific is expected to experience significant growth. Countries like India and China are emerging as key markets due to their large patient populations and growing investments in healthcare infrastructure development. Additionally, collaborations between healthcare providers and technology companies are expected to accelerate market growth in the region.
Leading Players in the Global Cardiovascular Devices Market
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Key Questions Answered in the Global Cardiovascular Devices Market
Global Cardiovascular Devices Market Overview
The huge rise in the prevalence of chronic heart disease is driving the growth of the global market for cardiovascular devices. This increase in demand is encouraging more healthcare providers to use cutting-edge cardiac technology for diagnostic and surgical applications. Additionally, the market has grown because of the declining costs of essential cardiovascular treatment devices, especially in developing countries like India.
Data based on the UK Biobank report, underscored the critical importance of investing in research and development efforts aimed at promoting cardiovascular health (CVH) and preventing cardiometabolic diseases. The findings reveal that maintaining ideal CVH significantly reduces the risk of all-cause and cardiometabolic disease-related mortality, leading to substantial gains in life expectancy. For instance, among participants with cardiometabolic disease, having ideal CVH was associated with life expectancy gains of 5.50 years for males and 4.20 years for females, at an index age of 45 years. As a result, rising market is predicted to be significantly impacted by surge in investments and fundings as well.
Global Cardiovascular Devices Market Growth Drivers
Rising Prevalence of Chronic Cardiac Diseases
Globally, the prevalence of chronic heart disease has significantly increased, which has raised demand for cardiovascular devices. Numerous reasons, such as sedentary lifestyles, improper diet, and an aging population are driving this trend. According to projections from the American Heart Association, in 2020, the percentage of global deaths attributed to cardiovascular disease escalated from 28.9% to 36.3%. Furthermore, in terms of years of lives lost, cardiovascular disease is anticipated to transition from the fourth to the foremost position in ranking. This is leading to an increased application of cardiovascular devices, intended to combat the burden of rising cardiac morbidities.
Advancements in Technology to Meet the Increasing Cardiovascular Devices Market Demand
Technological advancements in cardiovascular medicines have ushered in a transformative era, where innovations like minimally invasive procedures, advanced imaging techniques, and the integration of artificial intelligence (AI) are revolutionizing both surgical and diagnostic approaches. Notably, AI or machine learning algorithms have become indispensable tools in the diagnosis and treatment of acute stroke. It helps by automating the detection of intracranial hemorrhage and large vessel occlusions on CT scans, while also accurately identifying early ischemic changes without the need for diffusion-weighted MRI.
Reduced Prices of Cardiovascular Therapeutic Devices
The decreased prices of crucial cardiovascular therapeutic devices, such as coronary stents, have made treatments more accessible, particularly in developing countries. This affordability has led to increased adoption rates and a broader patient population seeking cardiac interventions.
Global Cardiovascular Devices Market Trends
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
Adoption of Remote Monitoring Technologies
Remote monitoring technologies, such as wearable devices and telemedicine solutions, enable continuous monitoring of cardiac health, improving patients care and outcomes. Cardiovascular devices are experiencing an increased integration of such technologies to expand its reach and facilitate more effective management of chronic cardiac conditions.
Growth in Demand for Transcatheter Therapies
Transcatheter therapies, including transcatheter aortic valve replacement (TVAR) and transcatheter mitral valve repair (TMVR), are gaining traction due to its minimally invasive nature and efficacy.
Expansion of Remote Consultation Services
This trend facilitates virtual appointments with cardiologists, enabling patients to receive timely guidance, and adjust treatment plans. This not only offers enhanced convenience for patients but also optimizes healthcare resources while reduces the burden on healthcare facilities.
Increased Consolidation and Strategic Acquisitions
In recent years, consolidation efforts and strategic acquisitions by major firms have increased significantly in the cardiovascular devices market. Through mergers and acquisitions businesses are actively looking to diversify their product lines, improve their technological prowess, and increase their market share. Through these calculated actions, businesses can have access to new technologies, intellectual properties, and distribution networks, improving their ability to adapt to changing consumer demands and market conditions. By encouraging innovation, optimizing processes, and eventually enhancing product offers and consumer pleasure, these consolidation attempts are changing the market. They may also result in more competition and efficiency.
Global Cardiovascular Devices Market Segmentation
Cardiovascular Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Device Type
- Diagnostic and Monitoring Devices
- Therapeutic and Surgical Devices
Market Breakup by Application
- Coronary Artery Disease
- Heart Failure
- Others
- Hospitals
- Specialty Clinics
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Segmentation Based on Device Types Poised for Growth
In terms of device types, the market segmentation includes diagnostic and monitoring devices, along with therapeutic and surgical devices. Diagnostic and monitoring devices encompass electrocardiography (ECG), remote cardiac monitoring, and other advanced technologies. The increasing prevalence of cardiovascular diseases, coupled with the rising demand for early detection and continuous monitoring, is expected to drive significant growth in this segment. On the other hand, therapeutic and surgical devices such as pacemakers, stents, heart valves, and other interventional tools are vital for treating various cardiovascular conditions. The adoption of minimally invasive procedures and advancements in device technologies are likely to propel the market share of this segment.
Market Breakdown by Applications set to Drive Market Growth
Market segmentation based on applications in the cardiovascular devices market includes coronary artery disease, heart failure, and other related conditions, reflecting the escalating global burden of these diseases and the demand for effective diagnostic and therapeutic interventions. The ARIC study estimates an annual incidence of 605,000 new myocardial infraction attacks and 200,000 recurrent attacks, with 170,000 categorized as silent events. Disparities in care are evident, as an analysis of the National inpatient sample revealed that females are less likely to undergo coronary intervention compared to males, with a consequent higher risk of mortality. Consequently, the market share based on application areas is projected to be contribute a significant value to the market.
Global Cardiovascular Devices Market Analysis by Region
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa are all included in the regional market analysis. With their sophisticated healthcare systems and presence of top medical device producers, North America and Europe are expected to hold a sizable portion of the market. Its supremacy is partly attributed to the existence of well-established healthcare systems and advantageous payment regulations. However, due to reasons like rising healthcare costs, and easier access to cutting-edge healthcare services, Asia Pacific is expected to experience significant growth. Countries like India and China are emerging as key markets due to their large patient populations and growing investments in healthcare infrastructure development. Additionally, collaborations between healthcare providers and technology companies are expected to accelerate market growth in the region.
Leading Players in the Global Cardiovascular Devices Market
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Boston Scientific Corporation
- Abbott
- Medtronic
- B. Braun SE
- Cardinal Health
- TERUMO CORPORATION
- Edwards Lifesciences Corporation
- GE HealthCare
- Siemens Healthcare Private Limited
- LivaNova PLC
- W. L. Gore & Associates, Inc.
- Shanghai MicroPort Medical (Group) Co., Ltd.
- AngioDynamics
- BD
- Koninklijke Philips N.V.
Key Questions Answered in the Global Cardiovascular Devices Market
- What was the global cardiovascular devices market value in 2024?
- What is the global Cardiovascular Devices Market Forecast outlook for 2025-2034?
- What factors contribute to global cardiovascular devices market demand?
- What are the major global cardiovascular devices market trends?
- What are the different categories of cardiovascular devices in terms of diagnostic and monitoring?
- What therapeutic and surgical devices are commonly used in cardiovascular interventions?
- How do these device types contribute to the overall market landscape?
- What are the primary applications for cardiovascular devices beyond coronary artery disease and heart failure?
- Which healthcare facilities primarily utilize cardiovascular devices, and why?
- What are the regional differences in the adoption and utilization of cardiovascular devices?
- How do market dynamics vary across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?
- Are these specific trends or challenges unique to each geographical region in the cardiovascular devices market?
- What is patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, and merges & acquisitions among the key market players shaping the market dynamics?
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Cardiovascular Devices Market Overview
- 3.1 Global Cardiovascular Devices Market Historical Value (2018-2024)
- 3.2 Global Cardiovascular Devices Market Forecast Value (2025-2034)
- 4 Global Cardiovascular Devices Market Landscape*
- 4.1 Global Cardiovascular Devices Market: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Cardiovascular Devices Market: Product Landscape
- 4.2.1 Analysis by Device Type
- 4.2.2 Analysis by Application
- 4.2.3 Analysis by End-User
- 5 Global Cardiovascular Devices Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Cardiovascular Devices Market Segmentation (218-2034)
- 6.1 Global Cardiovascular Devices Market (2018-2034) by Device Type
- 6.1.1 Market Overview
- 6.1.2 Diagnostic and Monitoring Devices
- 6.1.2.1 Electrocardiography (ECG)
- 6.1.2.2 Remote Cardiac Monitoring
- 6.1.2.3 Others
- 6.1.3 Therapeutic and Surgical Devices
- 6.1.3.1 Pacemakers
- 6.1.3.2 Stents
- 6.1.3.3 Heart Valve
- 6.1.3.4 Others
- 6.2 Global Cardiovascular Devices Market (2018-2034) by Application
- 6.2.1 Market Overview
- 6.2.2 Coronary Artery Disease
- 6.2.3 Heart Failure
- 6.2.4 Others
- 6.3 Global Cardiovascular Devices Market (2018-2034) by End User
- 6.3.1 Market Overview
- 6.3.2 Hospitals
- 6.3.3 Specialty Clinics
- 6.3.4 Others
- 6.4 Global Cardiovascular Devices Market (2018-2034) by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Cardiovascular Devices Market (218-2034)
- 7.1 North America Cardiovascular Devices Market (2018-2034) by Device Type
- 7.1.1 Market Overview
- 7.1.2 Diagnostic and Monitoring Devices
- 7.1.2.1 Electrocardiography (ECG)
- 7.1.2.2 Remote Cardiac Monitoring
- 7.1.2.3 Others
- 7.1.3 Therapeutic and Surgical Devices
- 7.1.3.1 Pacemakers
- 7.1.3.2 Stents
- 7.1.3.3 Others
- 7.2 North America Cardiovascular Devices Market (2018-2034) by Application
- 7.2.1 Market Overview
- 7.2.2 Coronary Artery Disease
- 7.2.3 Heart Failure
- 7.2.4 Others
- 7.3 North America Cardiovascular Devices Market (2018-2034) by Country
- 7.3.1 United States of America
- 7.3.2 Canada
- 8 Europe Cardiovascular Devices Market (218-2034)
- 8.1 Europe Cardiovascular Devices Market (2018-2034) by Device Type
- 8.1.1 Market Overview
- 8.1.2 Diagnostic and Monitoring Devices
- 8.1.2.1 Electrocardiography (ECG)
- 8.1.2.2 Remote Cardiac Monitoring
- 8.1.2.3 Others
- 8.1.3 Therapeutic and Surgical Devices
- 8.1.3.1 Pacemakers
- 8.1.3.2 Stents
- 8.1.3.3 Others
- 8.2 Europe Cardiovascular Devices Market (2018-2034) by Application
- 8.2.1 Market Overview
- 8.2.2 Coronary Artery Disease
- 8.2.3 Heart Failure
- 8.2.4 Others
- 8.3 Europe Cardiovascular Devices Market (2018-2034) by Country
- 8.3.1 United Kingdom
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Others
- 9 Asia Pacific Cardiovascular Devices Market (218-2034)
- 9.1 Asia Pacific Cardiovascular Devices Market (2018-2034) by Device Type
- 9.1.1 Market Overview
- 9.1.2 Diagnostic and Monitoring Devices
- 9.1.2.1 Electrocardiography (ECG)
- 9.1.2.2 Remote Cardiac Monitoring
- 9.1.2.3 Others
- 9.1.3 Therapeutic and Surgical Devices
- 9.1.3.1 Pacemakers
- 9.1.3.2 Stents
- 9.1.3.3 Others
- 9.2 Asia Pacific Cardiovascular Devices Market (2018-2034) by Application
- 9.2.1 Market Overview
- 9.2.2 Coronary Artery Disease
- 9.2.3 Heart Failure
- 9.2.4 Others
- 9.3 Asia Pacific Cardiovascular Devices Market (2018-2034) by Country
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 ASEAN
- 9.3.5 Australia
- 9.3.6 Others
- 10 Latin America Cardiovascular Devices Market (218-2034)
- 10.1 Latin America Cardiovascular Devices Market (2018-2034) by Device Type
- 10.1.1 Market Overview
- 10.1.2 Diagnostic and Monitoring Devices
- 10.1.2.1 Electrocardiography (ECG)
- 10.1.2.2 Remote Cardiac Monitoring
- 10.1.2.3 Others
- 10.1.3 Therapeutic and Surgical Devices
- 10.1.3.1 Pacemakers
- 10.1.3.2 Stents
- 10.1.3.3 Others
- 10.2 Latin America Cardiovascular Devices Market (2018-2034) by Application
- 10.2.1 Market Overview
- 10.2.2 Coronary Artery Disease
- 10.2.3 Heart Failure
- 10.2.4 Others
- 10.3 Latin America Cardiovascular Devices Market (2018-2034) by Country
- 10.3.1 Brazil
- 10.3.2 Argentina
- 10.3.3 Mexico
- 10.3.4 Others
- 11 Middle East and Africa Cardiovascular Devices Market (218-2034)
- 11.1 Middle East and Africa Cardiovascular Devices Market (2018-2034) by Device Type
- 11.1.1 Market Overview
- 11.1.2 Diagnostic and Monitoring Devices
- 11.1.2.1 Electrocardiography (ECG)
- 11.1.2.2 Remote Cardiac Monitoring
- 11.1.2.3 Others
- 11.1.3 Therapeutic and Surgical Devices
- 11.1.3.1 Pacemakers
- 11.1.3.2 Stents
- 11.1.3.3 Others
- 11.2 Middle East and Africa Cardiovascular Devices Market (2018-2034) by Application
- 11.2.1 Market Overview
- 11.2.2 Coronary Artery Disease
- 11.2.3 Heart Failure
- 11.2.4 Others
- 11.3 Middle East and Africa Cardiovascular Devices Market (2018-2034) by Country
- 11.3.1 Saudi Arabia
- 11.3.2 United Arab Emirates
- 11.3.3 Nigeria
- 11.3.4 South Africa
- 11.3.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Component of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Component of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Component of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Market Share by Top 5 Companies
- 17.2 Boston Scientific Corporation
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Abbott
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Medtronic
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 B. Braun SE
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Cardinal Health
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 TERUMO CORPORATION
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Edwards Lifesciences Corporation
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 GE HealthCare
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Siemens Healthcare Private Limited
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 LivaNova PLC
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 W. L. Gore & Associates, Inc.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Shanghai MicroPort Medical (Group) Co.,Ltd.
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 AngioDynamics
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 BD
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 17.16 Koninklijke Philips N.V.
- 17.16.1 Financial Analysis
- 17.16.2 Product Portfolio
- 17.16.3 Demographic Reach and Achievements
- 17.16.4 Mergers and Acquisitions
- 17.16.5 Certifications
- 18 Global Cardiovascular Devices Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
